Viewing Study NCT02747732


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-05-26 @ 6:14 AM
Study NCT ID: NCT02747732
Status: UNKNOWN
Last Update Posted: 2019-04-23
First Post: 2016-04-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL
Sponsor: Meirav Kedmi MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B Cell Lymphoma View
None Primary Mediastinal (Thymic) Large B-cell Lymphoma View
None Transformed Indolent Lymphoma View
None Recurrent Disease View
None Refractory Cancer View
Keywords: